Ulcerative colitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who can receive colonoscopic examination Patients who receive informed consents
Exclusion criteria
Exclusion criteria: Patients who cannot receive colonoscopic examination because of their poor clinical condition and bad diagnostic imaging Patients who refuse informed consents
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| vascular grading non-relapsing rates detection rates of both colonic cancer and dysplasia | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical activity index White blood cell count, Platelet count, Erythrocyte sedimentation rates, CRP Pathological Matts grading Endoscopic ultrasonographic evaluation Concordance of FICE appearance and pathological specimens | — |
Countries
Japan
Contacts
Saitama Medical Center, Saitama medical University Department og gastroenterology and Hepatology